NECOX
Price
$23.02
Change
+$0.34 (+1.50%)
Updated
Aug 12 closing price
Net Assets
1.09B
VIVAX
Price
$70.03
Change
+$0.74 (+1.07%)
Updated
Aug 12 closing price
Net Assets
195.81B
Interact to see
Advertisement

NECOX vs VIVAX

Header iconNECOX vs VIVAX Comparison
Open Charts NECOX vs VIVAXBanner chart's image
Natixis Oakmark C
Price$23.02
Change+$0.34 (+1.50%)
VolumeN/A
Net Assets1.09B
Vanguard Value Index I
Price$70.03
Change+$0.74 (+1.07%)
VolumeN/A
Net Assets195.81B
NECOX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NECOX vs. VIVAX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NECOX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 196B vs. NECOX (1.09B). VIVAX pays higher dividends than NECOX: VIVAX (2.06) vs NECOX (0.37). NECOX was incepted earlier than VIVAX: NECOX (30 years) vs VIVAX (33 years). NECOX (1.84) is less costly to investors than VIVAX (0.17). NECOX is a more actively managed with annual turnover of: 51.00 vs. VIVAX (9.00). NECOX has a lower initial minimum investment than VIVAX: NECOX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 9.23 vs. NECOX (2.92). VIVAX return over 5 years is better than : 66.39 vs. NECOX (29.46).
NECOXVIVAXNECOX / VIVAX
Total Expense Ratio1.780.171,047%
Annual Report Gross Expense Ratio1.840.171,082%
Fund Existence30 years33 years-
Gain YTD2.2544.93746%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B196B1%
Annual Yield % from dividends0.372.0618%
Returns for 1 year2.929.2332%
Returns for 3 years5.9224.7824%
Returns for 5 years29.4666.3944%
Returns for 10 years25.91111.7923%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMAB21.870.79
+3.75%
Genmab A/S ADS
PVLA43.211.50
+3.60%
Palvella Therapeutics Inc
KTTA0.700.02
+3.17%
Pasithea Therapeutics Corp
TRUP50.661.17
+2.36%
Trupanion
QIPT1.98-0.14
-6.60%
Quipt Home Medical Corp